DURHAM – Durham-based Precision Biosciences’ genome editing technology has drawn interest – and investment – from another global pharmaceutical giant. This time it’s Novartis. The two companies have ...

FARMINGDALE, N.Y. - December 5, 2018 - Precision Label Corporation, a New York-based converter serving major cosmetic brands, is expanding its digital production capabilities with the addition of ...

As fellow gene editing firm Crispr Therapeutics AG hosted an innovation day in which it confirmed plans for regulatory filings by year-end for an ex vivo gene editing therapy in sickle cell disease ...

Precision BioSciences Inc (NASDAQ: DTIL) and Tiziana Life Sciences plc (NASDAQ: TLSA) have announced an exclusive license agreement for Tiziana's foralumab. The companies plan to explore the fully ...

Under the agreement iECURE plans to advance Precision's PBGENE-PCSK9 candidate into Phase 1 studies and gain access to Precision's PCSK9-directed ARCUS nuclease to develop additional gene-editing ...

If the city of Gulf Shores doesn't consider a tattoo shop to be a family-friendly business, Motel McCready, owner of Precision Ink Tattoos, would strongly disagree. So would his wife, Lynn, one of the ...

DURHAM – Precision Biosciences has inked a deal with gene editing company iECURE to advance one of Precision’s drug candidates into Phase 1 clinical studies. The agreement also gives iECURE a license ...

Precision BioSciences, Inc. DTIL announced that it has entered into an exclusive license agreement with New York-based Tiziana Life Sciences plc TLSA to develop the latter’s fully human anti-CD3 ...

Researchers led by Patrick Smith of the University of Sheffield in the UK recently showed that they could print neuronal and other types of biological cells using a piezoelectric ink-jet printer. The ...